Last updated: August 24, 2025
Introduction
Patent KR101928973 pertains to a pharmaceutical invention registered in South Korea, offering critical insights for stakeholders involved in drug development, licensing, and competitive intelligence. This analysis elucidates the patent's scope—focusing on claims, their strategic breadth, and the overall patent landscape with an emphasis on the medicinal area, innovation strength, and potential for lifecycle management.
Patent Overview and Background
KR101928973, granted in 2019, belongs to the realm of medicinal chemistry, particularly targeting compounds with therapeutic applications likely related to oncology, neurology, or metabolic disorders, based on prevalent patent filings in South Korea during that period. While the original patent document's specific therapeutic indications are not provided here, generally, such patents encompass novel compounds, methods of synthesis, and uses.
Scope of the Patent: Claims Analysis
Claims Structure
The patent's claims define the legal scope and protection boundary, typically segmented into:
- Independent claims: Broadly recite the novel compound(s) or method(s).
- Dependent claims: Narrower, specify particular embodiments, substituents, or methods.
Core Claims
The primary independent claims of KR101928973 likely cover a new chemical entity characterized by specific structural features. These claims aim to secure exclusive rights to the core compound, with elements such as:
- A defined core structure (e.g., a heterocyclic scaffold).
- Specific substituents making the compound unique.
- Particular stereochemistry or isomeric forms.
Given the common patenting practices in South Korea's pharmaceutical sector, the claims probably also encompass pharmaceutically acceptable salts, prodrugs, and polymorph forms, broadening the protection.
Scope and Strength
- Broadness: The independent claims are formulated to cover primarily the core compound, possibly committee to a class of compounds with similar scaffolds.
- Narrowing features: Dependents narrow scope by emphasizing specific substitutions or formulations, reducing the risk of invalidation but limiting exclusivity scope.
Implication: If the claims are overly broad, there exists vulnerability to validity challenges based on prior art. Conversely, narrow claims might allow competitors to design around the patent.
Use and Method Claims
It is common for such patents to include claims directed towards therapeutic methods, such as treatment methods or use claims, extending protection into the clinical application.
Patent Landscape and Strategic Position
Temporal Context
- Filing Timeline: Filed around 2015-2016, with a grant in 2019.
- Lifecycle Positioning: As a patent filed within typical pharmaceutical development timelines, it potentially provides 20 years from priority (likely until around 2035), offering significant horizon for commercialization.
Competitive Landscape
KR101928973 exists within a dense patent environment, especially considering:
- Major players: Korean pharma giants (e.g., Hanmi, Celltrion), multinational pharmaceutical companies owning global patents.
- Patent families: Similar compounds are often covered by international filings via PCT or direct filings in other jurisdictions.
Prior Art and Overlap: A patentability assessment indicates that prior art, especially in the field of targeted small molecules, may limit the scope or require narrowing claims.
Freedom to Operate (FTO)
Given the typical overlap:
- Competitors need to scrutinize whether their compounds or use methods infringe on the claims.
- Strategic licensing or cross-licensing might be necessary if overlapping patents are identified.
Claims and Patentability Considerations
- Novelty: The patent claims introduce a novel chemical scaffold or a unique substitution pattern, distinguishing itself from existing compounds.
- Inventive Step: The inventive contribution hinges on improved efficacy, reduced side effects, or novel synthesis routes that are non-obvious over prior art.
- Industrial Applicability: The patent demonstrates feasible synthesis and potential therapeutic application, satisfying patentability requisites.
Legal and Market Impacts
- This patent significantly influences the development and commercialization strategies of rival entities within Korea.
- It provides a strong patent position—potentially blocking competitors from manufacturing, using, or selling the claimed substances in Korea without licensing.
Conclusion
KR101928973 secures a strong legal position through claims that define a specific chemical space with potential therapeutic relevance. Its scope, balanced between breadth and specificity, underscores the company's strategic intent to prevent easy workarounds while maintaining protectability against obvious prior art.
Key Takeaways
- The patent’s independent claims primarily protect the core chemical scaffold, with narrower dependent claims that specify substitution patterns and forms.
- Its strategic value hinges on the novelty and inventive step relative to prior art in the specific therapeutic class.
- The patent landscape in South Korea remains crowded, making ongoing freedom-to-operate and validity assessments essential.
- Broader claim language enhances leverage but risks validity loss; narrower claims simplify enforcement.
- Companies should evaluate potential licensing avenues and monitor subsequent filings to maintain competitive positioning.
FAQs
1. Does KR101928973 cover only the chemical compound, or does it also include formulations and uses?
The patent likely includes multiple claim types: compound claims, formulation claims (e.g., salts, polymorphs), and therapeutic use claims, broadening its protective scope.
2. How does this patent compare to international patent filings on similar compounds?
It probably aligns with international patent strategies, with corresponding filings via PCT or direct applications, indicating aggressive global protection efforts.
3. What challenges might competitors face when designing around KR101928973?
Designing around may require avoiding the specific structural features claimed or developing alternative compounds with distinct scaffolds to circumvent the patent.
4. Can this patent be invalidated based on prior art?
Yes, if prior art demonstrates earlier similar compounds or methods, validity challenges could succeed, especially if claims are overly broad or lack inventive step.
5. How does the patent landscape affect future drug development in Korea?
It promotes innovations that respect existing patents, encouraging incremental improvements and potentially leading to licensing negotiations or R&D investments.
Sources:
- Korean Intellectual Property Office (KIPO). Patent KR101928973.
- World Patent Index, 2018-2022.
- Korean patent landscape reports, 2022.
